AXP1275

· Axikin Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXP1275, covering 2016-02-05 to 2016-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma [Phase 2]

See pricing